Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2012
05/18/2012CA2812665A1 Pharmaceutical composition for treating hcv infections
05/18/2012CA2812598A1 Crystalline forms of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid
05/17/2012US20120124703 Novel coprinus comatus and tremella mesenterica mushroom strains, products and extracts thereof and compositions comprising them
05/17/2012US20120124683 Delivery method
05/17/2012US20120124681 Dna fragment and pharmaceutical composition
05/17/2012US20120123182 Devices for thermally induced transformations controlled by irradiation of functionalized fullerenes
05/17/2012US20120123102 Modified pectins, compositions and methods related thereto
05/17/2012US20120122995 Anti-Inflammatory Agent and Cancer-Preventive Agent Comprising Canolol or Prodrug Thereof and Pharmaceutical, Cosmetic and Food Comprising the Same
05/17/2012US20120122993 Pharmaceutical composition containing 1h-inden-1-amine, 2,3-dihydro-n-2-propynyl-(1r)-, methanesulfonate
05/17/2012US20120122992 SMALL MOLECULE INHIBITORS OF Dusp6 AND USES THEREFOR
05/17/2012US20120122991 Method for treating cancer by increasing amp-activated kinase activity
05/17/2012US20120122990 Oleoylethanolamide based functional mesophases
05/17/2012US20120122989 Method of enhancing hair growth
05/17/2012US20120122988 4-(phenoxyalkyl)thio)-phenoxyacetic acids and analogs
05/17/2012US20120122987 Treatment of disorders associated with g protein-coupled receptor 35 (gpr35)
05/17/2012US20120122986 Methods of Treating Fragile X Syndrome
05/17/2012US20120122985 Tranexamic Acid Formulations
05/17/2012US20120122984 Methods of Treating Lipomas and Liposarcomas
05/17/2012US20120122983 Deodorized edible oil or fat with low levels of bound mcpd and process of making by carboxymethyl cellulose and/or resin purification
05/17/2012US20120122982 Use of pufas to treat nerve damage
05/17/2012US20120122981 Biomarkers Related to Insulin Resistance and Methods using the Same
05/17/2012US20120122978 Use of Ketogenic Compounds for Treatment of Age-Associated Memory Impairment
05/17/2012US20120122977 Substituted amino bisphenyl pentanoic acid derivatives as NEP inhibitors
05/17/2012US20120122976 Phosphate-free pharmaceutical composition for the treatment of glaucoma
05/17/2012US20120122974 Hair restorer
05/17/2012US20120122973 Dry processing of retigabine
05/17/2012US20120122972 Novel eicosanoid derivatives
05/17/2012US20120122971 New process for preparing hydroxylamines and medicaments
05/17/2012US20120122969 Treatment of pervasive developmental disorders with tocotrienols or tocotrienol enriched extracts
05/17/2012US20120122968 Use of dynamin ring stabilizers
05/17/2012US20120122967 Compositions and products containing r-equol, and methods for their making
05/17/2012US20120122966 Use of organic dyes as analgesic agents
05/17/2012US20120122964 Bicyclic compound and use thereof for medical purposes
05/17/2012US20120122963 Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex dna
05/17/2012US20120122962 Modified Small Interfering RNA Molecules and Methods of Use
05/17/2012US20120122961 RNAi Inhibition of Serum Amyloid A For Treatment of Glaucoma
05/17/2012US20120122960 Organic Compositions to Treat Beta-ENaC-Related Diseases
05/17/2012US20120122959 Targeting MicroRNAs for Metabolic Disorders
05/17/2012US20120122958 Transcriptional repression leading to parkinson's disease
05/17/2012US20120122957 Regulation of aging by modulation of mitochondrial function
05/17/2012US20120122956 Methods for inhibiting angiogenesis with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin
05/17/2012US20120122955 Use of lna apob antisense oligomers for the treatment of acute coronary syndromes
05/17/2012US20120122954 Antisense Oligomers Targeting PCSK9
05/17/2012US20120122953 Methods for enhancing utrophin production via inhibition of microrna
05/17/2012US20120122952 4-hydroxybutyric acid analogs
05/17/2012US20120122951 Skin-whitening agent and cosmetic method for whitening skin
05/17/2012US20120122950 Libraries of 1-(sulfonyl)-n-phenylpyrrolidine-2-carboxamides for drug discovery
05/17/2012US20120122949 Ultra-high strength injectable hydrogel and process for producing the same
05/17/2012US20120122948 3-alkyl-5-fluoroindole derivatives as myeloperoxidase inhibitors
05/17/2012US20120122947 Spiro-oxindole mdm2 antagonists
05/17/2012US20120122946 Polymorphisms for predicting disease and treatment outcome
05/17/2012US20120122945 Ester pro-drugs of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl] methanol
05/17/2012US20120122944 Tetrahydronaphthalene derivatives
05/17/2012US20120122943 Melampomagnolide B Derivatives as Antileukemic and Cytotoxic Agents
05/17/2012US20120122942 5-oxo-ete receptor antagonist compounds
05/17/2012US20120122941 Cycloalkylamine derivatives
05/17/2012US20120122940 Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas
05/17/2012US20120122939 Alkylsulfonyl-substituted thiazolide compounds
05/17/2012US20120122938 Alkoxy Compounds for Disease Treatment
05/17/2012US20120122937 Methods for inhibiting cancer cell proliferation and inducing cancer cell apoptosis
05/17/2012US20120122935 Compositions and methods for treating necrotizing enterocolitis
05/17/2012US20120122934 4-(p-QUINONYL)-2-HYDROXYBUTANAMIDE DERIVATIVES FOR TREATMENT OF MITOCHONDRIAL DISEASES
05/17/2012US20120122933 Compounds
05/17/2012US20120122932 Methods and Compositions for Controlling Ectoparasites
05/17/2012US20120122931 Indole derivative or pharmaceutically acceptable salt thereof
05/17/2012US20120122930 1H-Benzimidazole-5-Carboxamides As Anti-Inflammatory Agents
05/17/2012US20120122927 3 or 4-substituted piperidine compounds
05/17/2012US20120122926 Biphenyl compounds useful as muscarinic receptor antagonists
05/17/2012US20120122925 Perhexiline for use in the treatment of hypertrophic cardiomyopathy (hcm)
05/17/2012US20120122924 Nampt inhibitors
05/17/2012US20120122923 Dual molecules containing a peroxide derivative, their synthesis and therapeutic uses
05/17/2012US20120122922 Compositions of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
05/17/2012US20120122921 Process for making modulators of cystic fibrosis transmembrane conductance regulator
05/17/2012US20120122920 Libraries of n-substituted-n-phenylethylsulfonamides for drug discovery
05/17/2012US20120122919 Pharmaceutical composition combining tenatoprazole and a histamine h2-receptor antagonist
05/17/2012US20120122918 Antibacterial agents
05/17/2012US20120122917 Method For Treatment Of HIV And Diseases Of Immune Dysregulation
05/17/2012US20120122916 Screening molecules with anti-prion activity: kits, methods and screened molecules
05/17/2012US20120122915 Crystalline forms of palonosetron hydrochloride
05/17/2012US20120122914 Sustained-release composition containing tetrahydropyrido[4,3-b]indole derivatives and preparation of the derivatives
05/17/2012US20120122913 Combination of curcuminoids and mtor inhibitors for the treatment of tauopathies
05/17/2012US20120122912 Novel spiro compounds useful as inhibitors of stearoyl-coenzyme a delta-9 desaturase
05/17/2012US20120122911 Piperidinone carboxamide azaindane cgrp receptor antagonists
05/17/2012US20120122910 Method of treating cancer using a survivin inhibitor
05/17/2012US20120122909 Spiro-oxindole compounds and their uses as therapeutic agents
05/17/2012US20120122908 Novel C-4 Substituted Retinoids
05/17/2012US20120122907 Novel Pyrazole Derivatives and their use as Positive Allosteric Modulators of Metabotropic Glutamate Receptors
05/17/2012US20120122906 Novel sulfonamide derivative and pharmaceutical product containing same
05/17/2012US20120122905 Novel gpr 119 agonists
05/17/2012US20120122904 Solid forms of (s)-2-amino-3-(4-(2-amino-6-((r)-1-(4-chloro-2-(3-methyl-1h-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)pyrimidin-4-yl)phenyl)propanoic acid
05/17/2012US20120122903 1-h-quinazoline-2, 4-diones for use in the treatment of neuronal ceroid lipofuscinosis
05/17/2012US20120122902 Pyrimidine derivative, preparation method and use thereof
05/17/2012US20120122901 Pyrrolo[2,3-d]pyrimidine compounds
05/17/2012US20120122900 Piperidinone carboxamide azaindane cgrp receptor antagonists
05/17/2012US20120122899 Piperidinone carboxamide azaindane cgrp receptor antagonists
05/17/2012US20120122898 Solid forms of 3-(4-(aminomethyl)-1-(5-methyl-7h-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamido)phenyl dimethylcarbamate
05/17/2012US20120122897 Methods of treating patients suffering from movement disorders
05/17/2012US20120122896 2,1,3-benzoxadiazol derivatives for the inhibition of influenza a and b virus and respiratory syncytial virus replication
05/17/2012US20120122895 5,6-bicyclic heteroaryl-containing urea compounds as kinase inhibitors
05/17/2012US20120122894 Inhibitors of bruton's tyrosine kinase
1 ... 1225 1226 1227 1228 1229 1230 1231 1232 1233 1234 1235 1236 1237 1238 1239 1240 1241 1242 1243 1244 1245 ... 7860